120 related articles for article (PubMed ID: 34229038)
1. A Global Survey of Physicians Knowledge About Nonalcoholic Fatty Liver Disease.
Younossi ZM; Ong JP; Takahashi H; Yilmaz Y; Eguc Hi Y; El Kassas M; Buti M; Diago M; Zheng MH; Fan JG; Yu ML; Wai-Sun Wong V; Alswat K; Chan WK; Mendez-Sanchez N; Burra P; Bugianesi E; Duseja AK; George J; Papatheodoridis GV; Saeed H; Castera L; Arrese M; Kugelmas M; Romero-Gomez M; Alqahtani S; Ziayee M; Lam B; Younossi I; Racila A; Henry L; Stepanova M;
Clin Gastroenterol Hepatol; 2022 Jun; 20(6):e1456-e1468. PubMed ID: 34229038
[TBL] [Abstract][Full Text] [Related]
2. Global survey of stigma among physicians and patients with nonalcoholic fatty liver disease.
Younossi ZM; Alqahtani SA; Alswat K; Yilmaz Y; Keklikkiran C; Funuyet-Salas J; Romero-Gómez M; Fan JG; Zheng MH; El-Kassas M; Castera L; Liu CJ; Wai-Sun Wong V; Zelber-Sagi S; Allen AM; Lam B; Treeprasertsuk S; Hameed S; Takahashi H; Kawaguchi T; Schattenberg JM; Duseja A; Newsome PN; Francque S; Spearman CW; Castellanos Fernández MI; Burra P; Roberts SK; Chan WK; Arrese M; Silva M; Rinella M; Singal AK; Gordon S; Fuchs M; Alkhouri N; Cusi K; Loomba R; Ranagan J; Eskridge W; Kautz A; Ong JP; Kugelmas M; Eguchi Y; Diago M; Yu ML; Gerber L; Fornaresio L; Nader F; Henry L; Racila A; Golabi P; Stepanova M; Carrieri P; Lazarus JV;
J Hepatol; 2024 Mar; 80(3):419-430. PubMed ID: 37984709
[TBL] [Abstract][Full Text] [Related]
3. Understanding Primary Care Physician Perspectives on the Diagnosis and Management of Non-Alcoholic Fatty Liver Disease: A Qualitative Study.
Heredia NI; John JC; Singh S; Hwang JP; Strong LL; Balakrishnan M; McNeill LH
Inquiry; 2024; 61():469580241241272. PubMed ID: 38529894
[TBL] [Abstract][Full Text] [Related]
4. The burden of nonalcoholic fatty liver disease (NAFLD) is rapidly growing in every region of the world from 1990 to 2019.
Paik JM; Henry L; Younossi Y; Ong J; Alqahtani S; Younossi ZM
Hepatol Commun; 2023 Oct; 7(10):. PubMed ID: 37782469
[TBL] [Abstract][Full Text] [Related]
5. The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review.
Younossi ZM; Golabi P; Paik JM; Henry A; Van Dongen C; Henry L
Hepatology; 2023 Apr; 77(4):1335-1347. PubMed ID: 36626630
[TBL] [Abstract][Full Text] [Related]
6. Frontiers of Collaboration between Primary Care and Specialists in the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease: A Review.
Nagai K; Nagai K; Iwaki M; Kobayashi T; Nogami A; Oka M; Saito S; Yoneda M
Life (Basel); 2023 Oct; 13(11):. PubMed ID: 38004284
[TBL] [Abstract][Full Text] [Related]
7. The Surreptitious Burden of Nonalcoholic Fatty Liver Disease in the Elderly in the Asia-Pacific Region: An Insight from the Global Burden of Disease Study 2019.
Danpanichkul P; Kongarin S; Permpatdechakul S; Polpichai N; Duangsonk K; Manosroi W; Chaiyakunapruk N; Mousa OY; Kim D; Chen VL; Wijarnpreecha K
J Clin Med; 2023 Oct; 12(20):. PubMed ID: 37892594
[TBL] [Abstract][Full Text] [Related]
8. Nonalcoholic Fatty Liver Disease as a Systemic Disease and the Need for Multidisciplinary Care.
Yoneda M; Kobayashi T; Iwaki M; Nogami A; Saito S; Nakajima A
Gut Liver; 2023 Nov; 17(6):843-852. PubMed ID: 37560797
[TBL] [Abstract][Full Text] [Related]
9. Safety-Net Primary Care and Endocrinology Clinicians' Knowledge and Perspectives on Screening for Nonalcoholic Fatty Liver Disease: A Mixed-Methods Evaluation.
Fantasia KL; Austad K; Mohanty A; Long MT; Walkey A; Drainoni ML
Endocr Pract; 2024 Mar; 30(3):270-277. PubMed ID: 38184239
[TBL] [Abstract][Full Text] [Related]
10. Obesity management for the hepatologist-What to do, how to do it and why?
Watt KD; Paul S; Khan MQ; Siddiqui M; Lam J; Diwan TS; Camilleri M
Hepatology; 2023 Sep; ():. PubMed ID: 37725761
[TBL] [Abstract][Full Text] [Related]
11. NAFLD: Diagnostics and New Nomenclature.
Kanagalingam G; Sanyal AJ
J Clin Exp Hepatol; 2023; 13(5):723-724. PubMed ID: 37693255
[No Abstract] [Full Text] [Related]
12. American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings: Co-Sponsored by the American Association for the Study of Liver Diseases (AASLD).
Cusi K; Isaacs S; Barb D; Basu R; Caprio S; Garvey WT; Kashyap S; Mechanick JI; Mouzaki M; Nadolsky K; Rinella ME; Vos MB; Younossi Z
Endocr Pract; 2022 May; 28(5):528-562. PubMed ID: 35569886
[TBL] [Abstract][Full Text] [Related]
13. A global view of the interplay between non-alcoholic fatty liver disease and diabetes.
Stefan N; Cusi K
Lancet Diabetes Endocrinol; 2022 Apr; 10(4):284-296. PubMed ID: 35183303
[TBL] [Abstract][Full Text] [Related]
14. Advancing the global public health agenda for NAFLD: a consensus statement.
Lazarus JV; Mark HE; Anstee QM; Arab JP; Batterham RL; Castera L; Cortez-Pinto H; Crespo J; Cusi K; Dirac MA; Francque S; George J; Hagström H; Huang TT; Ismail MH; Kautz A; Sarin SK; Loomba R; Miller V; Newsome PN; Ninburg M; Ocama P; Ratziu V; Rinella M; Romero D; Romero-Gómez M; Schattenberg JM; Tsochatzis EA; Valenti L; Wong VW; Yilmaz Y; Younossi ZM; Zelber-Sagi S;
Nat Rev Gastroenterol Hepatol; 2022 Jan; 19(1):60-78. PubMed ID: 34707258
[TBL] [Abstract][Full Text] [Related]
15. Incorporating fatty liver disease in multidisciplinary care and novel clinical trial designs for patients with metabolic diseases.
Eslam M; Ahmed A; Després JP; Jha V; Halford JCG; Wei Chieh JT; Harris DCH; Nangaku M; Colagiuri S; Targher G; Joshi S; Byrne CD; Khunti K; Nguyen MH; Gish RG; George J
Lancet Gastroenterol Hepatol; 2021 Sep; 6(9):743-753. PubMed ID: 34265276
[TBL] [Abstract][Full Text] [Related]
16. Review article: non-alcoholic fatty liver disease and cardiovascular diseases: associations and treatment considerations.
Polyzos SA; Kechagias S; Tsochatzis EA
Aliment Pharmacol Ther; 2021 Oct; 54(8):1013-1025. PubMed ID: 34416040
[TBL] [Abstract][Full Text] [Related]
17. AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease.
Rinella ME; Neuschwander-Tetri BA; Siddiqui MS; Abdelmalek MF; Caldwell S; Barb D; Kleiner DE; Loomba R
Hepatology; 2023 May; 77(5):1797-1835. PubMed ID: 36727674
[No Abstract] [Full Text] [Related]
18. The EASL-Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality.
Karlsen TH; Sheron N; Zelber-Sagi S; Carrieri P; Dusheiko G; Bugianesi E; Pryke R; Hutchinson SJ; Sangro B; Martin NK; Cecchini M; Dirac MA; Belloni A; Serra-Burriel M; Ponsioen CY; Sheena B; Lerouge A; Devaux M; Scott N; Hellard M; Verkade HJ; Sturm E; Marchesini G; Yki-Järvinen H; Byrne CD; Targher G; Tur-Sinai A; Barrett D; Ninburg M; Reic T; Taylor A; Rhodes T; Treloar C; Petersen C; Schramm C; Flisiak R; Simonova MY; Pares A; Johnson P; Cucchetti A; Graupera I; Lionis C; Pose E; Fabrellas N; Ma AT; Mendive JM; Mazzaferro V; Rutter H; Cortez-Pinto H; Kelly D; Burton R; Lazarus JV; Ginès P; Buti M; Newsome PN; Burra P; Manns MP
Lancet; 2022 Jan; 399(10319):61-116. PubMed ID: 34863359
[No Abstract] [Full Text] [Related]
19. Clinical and Patient-Reported Outcomes From Patients With Nonalcoholic Fatty Liver Disease Across the World: Data From the Global Non-Alcoholic Steatohepatitis (NASH)/ Non-Alcoholic Fatty Liver Disease (NAFLD) Registry.
Younossi ZM; Yilmaz Y; Yu ML; Wai-Sun Wong V; Fernandez MC; Isakov VA; Duseja AK; Mendez-Sanchez N; Eguchi Y; Bugianesi E; Burra P; George J; Fan JG; Papatheodoridis GV; Chan WK; Alswat K; Saeed HS; Singal AK; Romero-Gomez M; Gordon SC; Roberts SK; El Kassas M; Kugelmas M; Ong JP; Alqahtani S; Ziayee M; Lam B; Younossi I; Racila A; Henry L; Stepanova M;
Clin Gastroenterol Hepatol; 2022 Oct; 20(10):2296-2306.e6. PubMed ID: 34768009
[TBL] [Abstract][Full Text] [Related]
20. Clinical Care Pathway for the Risk Stratification and Management of Patients With Nonalcoholic Fatty Liver Disease.
Kanwal F; Shubrook JH; Adams LA; Pfotenhauer K; Wai-Sun Wong V; Wright E; Abdelmalek MF; Harrison SA; Loomba R; Mantzoros CS; Bugianesi E; Eckel RH; Kaplan LM; El-Serag HB; Cusi K
Gastroenterology; 2021 Nov; 161(5):1657-1669. PubMed ID: 34602251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
